MLTX
#2185
MoonLake Immunotherapeutics - Class A Ordinary Shares
20.4 1 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.25%
Monthly Change
+8.28%
6 month change
+24.13%
Year Change
+113.49%
Previous Close
20.3 6
Open
20.4 1
Low
20.4 1
High
20.4 1
Volume
77
Financials
- Market Capitalization 1.5 B
- Employee 130
- Founded 2020
- CEO N/A
- Website www.moonlaketx.com
- Headquarter Cayman Islands
- FIGI BBG00XQZQTS9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.73
Price to sales ratio
1 418.42
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2168 |  SEPN Septerna, Inc. - Common Stock | 34.36 USD | -4.37% | -5.21% | -5.27% | +56.11% | 1.55 B USD | ||
| 2170 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.38 USD | -15.14% | -16.07% | -7.56% | +103.02% | 1.55 B USD | ||
| 2204 |  NVAX Novavax, Inc. - Common Stock | 8.91 USD | -4.50% | -4.60% | -2.84% | +26.92% | 1.47 B USD | ||
| 2235 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.16 USD | -2.16% | -3.09% | +20.18% | +49.45% | 1.41 B USD |
Frequently asked questions about MoonLake Immunotherapeutics - Class A Ordinary Shares
What is the MoonLake Immunotherapeutics - Class A Ordinary Shares stock price today?
The current price of MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX) is 20.41. Over the past 24 hours, the stock has changed by +0.25%. Follow the MLTX chart for real-time price dynamics.
What is the stock ticker of MoonLake Immunotherapeutics - Class A Ordinary Shares?
MoonLake Immunotherapeutics - Class A Ordinary Shares trades under the ticker MLTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MoonLake Immunotherapeutics - Class A Ordinary Shares stock going up?
MLTX has changed by +9.14% over the last week, +8.28% over the last month, and +113.49% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MoonLake Immunotherapeutics - Class A Ordinary Shares net income for the last quarter?
MoonLake Immunotherapeutics - Class A Ordinary Shares reported net income of -69.71 M for the last quarter. The previous quarter showed -62.42 M, which means net income changed by -11.67%.
How many employees does MoonLake Immunotherapeutics - Class A Ordinary Shares have?
As of the latest available data, MoonLake Immunotherapeutics - Class A Ordinary Shares has 130 employees. Workforce size can provide additional context about the company's scale and operations.
What is MoonLake Immunotherapeutics - Class A Ordinary Shares EBITDA?
MoonLake Immunotherapeutics - Class A Ordinary Shares EBITDA is -69.12 M, and its EBITDA margin is -123.43 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MoonLake Immunotherapeutics - Class A Ordinary Shares stock?
You can buy MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MoonLake Immunotherapeutics - Class A Ordinary Shares stock?
Investing in MoonLake Immunotherapeutics - Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MLTX chart and related analysis on metatrader.com as part of your research.